Cardiawave is a medical device company .
Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 27, 2018 | Series Unknown | $8.20M | 2 | — | — | Detail |
Mar 2, 2017 | Series Unknown | €1.40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European program Instrument PME | — | Series Unknown |
Business Angels des Grandes Ecoles | — | Series Unknown |